Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Astrocytoma × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Carcinoma, Renal Cell 31 Neuroendocrine Tumors 13 Neoplasms 12 Neoplasm Metastasis 10 Carcinoma, Non-Small-Cell Lung 8 Carcinoma 7 Tuberous Sclerosis 5 Kidney Neoplasms 5 Carcinoma, Hepatocellular 5 Carcinoid Tumor 5 Adenoma, Islet Cell 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma 3 Colorectal Neoplasms 3 Adenocarcinoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Neuroectodermal Tumors, Primitive 2 Lymphoproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell 2 Lymphatic Diseases 2 Lymphangioleiomyomatosis 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2

Interventions

Temozolomide 16 Radiotherapy 7 Flucytosine 6 vocimagene amiretrorepvec 5 Surgical Procedures, Operative 5 Lomustine 4 IL13-PE38 4 Corticotropin-Releasing Hormone 3 Chlorotoxin 3 Carmustine 3 Bevacizumab 3 vorasidenib 2 trametinib 2 tovorafenib 2 regorafenib 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 dabrafenib 2 Valacyclovir 2 Trabedersen 2 Radiation 2 OKN 007 2 Nivolumab 2 Drug Delivery Systems 2 Carboplatin 2 Cancer Vaccines 2 Adjuvants, Immunologic 2 trastuzumab deruxtecan 1 talampanel 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00789828 2016-02-03

EXIST-1

Novartis

Phase 3 Completed

117 enrolled 15 charts

Astrocytoma, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡